Predictive Oncology Company Top Insiders

Predictive Oncology Management Team Effectiveness

The company has return on total asset (ROA) of (0.732) % which means that it has lost $0.732 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.9037) %, meaning that it created substantial loss on money invested by shareholders. Predictive Oncology's management efficiency ratios could be used to measure how well Predictive Oncology manages its routine affairs as well as how well it operates its assets and liabilities. The Predictive Oncology's current Return On Equity is estimated to increase to 63.23, while Return On Tangible Assets are projected to decrease to (2.69). As of now, Predictive Oncology's Net Tangible Assets are increasing as compared to previous years. The Predictive Oncology's current Common Stock Shares Outstanding is estimated to increase to about 5.7 M, while Net Loss is projected to decrease to (24.3 M).

Predictive Oncology Workforce Comparison

Predictive Oncology Insider Trading

Predictive Oncology Notable Stakeholders

The success or failure of an entity such as Predictive Oncology often depends on how effective the management is. Predictive Oncology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Predictive management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Predictive management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Predictive Oncology's price analysis, check to measure Predictive Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predictive Oncology is operating at the current time. Most of Predictive Oncology's value examination focuses on studying past and present price action to predict the probability of Predictive Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predictive Oncology's price. Additionally, you may evaluate how the addition of Predictive Oncology to your portfolios can decrease your overall portfolio volatility.